Your browser doesn't support javascript.
loading
Real world data study of prevalence and direct costs related to dengue management in Brazil's private healthcare from 2015 to 2020.
Abud, Denise Alves; Santos, Claudia Yang; Neto, Abner Augusto Lobao; Senra, Juliana Tosta; Tuboi, Suely.
Afiliación
  • Abud DA; Takeda Pharmaceuticals Brazil, Brazil.
  • Santos CY; Takeda Pharmaceuticals Brazil, Brazil.
  • Neto AAL; Takeda Pharmaceuticals Brazil, Brazil.
  • Senra JT; Takeda Pharmaceuticals Brazil, Brazil.
  • Tuboi S; Takeda Pharmaceuticals Brazil, Brazil. Electronic address: suely.tuboi@takeda.com.
Braz J Infect Dis ; 26(6): 102718, 2022.
Article en En | MEDLINE | ID: mdl-36423695
BACKGROUND: The burden of dengue in Brazil is poorly documented and is based on data from the public health care setting. This study estimated the prevalence and costs of dengue management in the private health care system in Brazil from 2015 to 2020 using a large claims database from Orizon. METHODS: We selected claims with dengue ICD codes (ICD-10 A90 or A91) from January 2015 to December 2020. Prevalence was estimated based on the population enrolled in health insurance plans in the given year. Costs were adjusted for the inflation up to December 2021 and evaluated by measures of central tendency and dispersion. RESULTS: A total of 63,882 unique beneficiaries were included, with a total of 64,186 dengue cases. The year with the highest prevalence was 2015 (1.6% of patients who used health plans), and there was also an increase in cases in 2016 and 2019. The median cost per hospitalization in 2015 was US$486.17, and in 2020, it reached US$696.72. The median cost of a case seen at an emergency room ranged from US$ 97.78 in 2015 to US$ 118.16 in 2017. CONCLUSIONS: The estimated prevalence of dengue in this population of private health-insured patients followed the epidemiological trends of the general population in Brazil, with the highest rates in 2015, 2016, and 2019. The cost of dengue management has increased in the private health care setting over the years.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Atención a la Salud / Dengue Tipo de estudio: Health_economic_evaluation / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: Braz J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Brasil
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Atención a la Salud / Dengue Tipo de estudio: Health_economic_evaluation / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: Braz J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Brasil